Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Cocrystal Pharma, Inc. |
Description | About Overview Management Team Board of Directors Scientific Advisors Partnerships & Licensing Careers Technology Development Pipeline Overview Coronaviru |
Keywords | N/A |
WebSite | cocrystalpharma.com |
Host IP | 54.208.101.55 |
Location | United States |
Site | Rank |
US$16,979,221
Last updated: 2023-04-30 11:34:51
cocrystalpharma.com has Semrush global rank of 623,368. cocrystalpharma.com has an estimated worth of US$ 16,979,221, based on its estimated Ads revenue. cocrystalpharma.com receives approximately 1,959,141 unique visitors each day. Its web server is located in United States, with IP address 54.208.101.55. According to SiteAdvisor, cocrystalpharma.com is safe to visit. |
Purchase/Sale Value | US$16,979,221 |
Daily Ads Revenue | US$15,674 |
Monthly Ads Revenue | US$470,194 |
Yearly Ads Revenue | US$5,642,326 |
Daily Unique Visitors | 130,610 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cocrystalpharma.com. | A | 3599 | IP: 54.208.101.55 |
cocrystalpharma.com. | NS | 3600 | NS Record: ns42.domaincontrol.com. |
cocrystalpharma.com. | NS | 3600 | NS Record: ns41.domaincontrol.com. |
cocrystalpharma.com. | MX | 1800 | MX Record: 0 cocrystalpharma-com.mail.protection.outlook.com. |
cocrystalpharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
cocrystalpharma.com. | TXT | 3600 | TXT Record: MS=ms38279757 |
About Overview Management Team Board of Directors Scientific Advisors Partnerships & Licensing Careers Technology Development Pipeline Overview Coronavirus Influenza Norovirus Hepatitis C News/Media Press Releases Presentations Fact Sheet Posters Media Investors Overview Analyst Coverage News / Events IR Calendar Presentations Company Information Financial Information Stock Data SEC Filings Corporate Governance Contact Us We are a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of coronaviruses (including SARS-CoV-2), influenza viruses, noroviruses and hepatitis C viruses. We employ a unique structure-based drug discovery technology platform and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. We are leveraging our core competencies and decade of experience in antiviral therapeutics to combat pandemic and seasonal influenza and the global COVID-19 health crisis. Given the |
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 06:51:35 GMT Server: Apache Location: http://www.cocrystalpharma.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 302 Moved Temporarily Content-Type: text/html; charset=UTF-8 Date: Sat, 23 Oct 2021 06:51:35 GMT Location: https://www.cocrystalpharma.com/ Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Sat, 23 Oct 2021 06:51:35 GMT Server: Apache Content-Type: text/html; charset=UTF-8 |
Domain Name: COCRYSTALPHARMA.COM Registry Domain ID: 1837844640_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2018-12-07T20:08:37Z Creation Date: 2013-12-03T23:17:49Z Registry Expiry Date: 2022-12-03T23:17:49Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS41.DOMAINCONTROL.COM Name Server: NS42.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T18:27:35Z <<< |